Financial calendar for the 2010 financial year of ALK-Abelló A/S
December 18, 2009 07:21 ET
|
ALK Abello
Annual report 2009 February 23, 2010
Annual General Meeting to be held March 26, 2010
at ALK at 4.00 p.m.
Bøge Allé 1
2970 Hørsholm, Denmark
Deadline for submission of written...
Report on transactions with ALK-Abelló A/S shares and associated securities by managerial staff and their related parties
December 02, 2009 08:58 ET
|
ALK Abello
Pursuant to section 28(a) of the Danish Securities Trading Act, ALK-Abelló A/S
shall report transactions with ALK-Abelló A/S' shares and associated securities
by managerial staff and their related...
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
December 02, 2009 08:58 ET
|
ALK Abello
I henhold til værdipapirhandelslovens § 28a følger hermed indberetning af
ledende medarbejderes og disses nærtståendes transaktioner med ALK-Abelló A/S'
aktier og tilknyttede værdipapirer:
Navn ...
Tildeling af aktieoptioner til direktion og ledende medarbejdere
November 19, 2009 08:43 ET
|
ALK Abello
Bestyrelsen har i overensstemmelse med retningslinjerne for
incitamentsaflønning som vedtaget på selskabets generalforsamling besluttet at
foretage en tildeling af
aktieoptioner. Der bliver i alt...
Grant of share options to members of the Board of Management and senior managers
November 19, 2009 08:43 ET
|
ALK Abello
According to the guidelines for incentive pay adopted by the annual general
meeting, the Board of Directors has passed a resolution to grant share options.
A total of 59,000 share options will be...
Nine-month interim report (Q3) 2009
November 19, 2009 05:40 ET
|
ALK Abello
(unaudited)
Financial performance in the nine months ended September 30, 2009
(Comparative figures for the same period last year are shown in brackets)
- Sales growth continued in Q3 and organic...
Delårsrapport 9 måneder (Q3) 2009
November 19, 2009 05:40 ET
|
ALK Abello
(urevideret)
Økonomiske resultater for perioden
(Sammenligningstal for samme periode sidste år er anført i parentes)
- Salgsvæksten fortsatte i tredje kvartal, og den organiske vækst i
vaccinesalget...
Dato for offentliggørelse af delårsrapport for 9 måneder (Q3) 2009 for ALK
November 13, 2009 02:21 ET
|
ALK Abello
Torsdag den 19. november 2009 offentliggør ALK delårsrapport for 9 måneder (Q3)
2009.
ALK afholder samme dag kl. 15.30 (CET) en telefonkonference for analytikere og
investorer, hvor adm. direktør...
Release date of nine-month interim report (Q3) 2009 for ALK
November 13, 2009 02:21 ET
|
ALK Abello
On Thursday, November 19, 2009, ALK releases its interim report for the nine
months ended September 30, 2009.
ALK will hold a conference call for analysts and investors that day at 3.30
p.m. (CET)...
GRAZAX® trial in the US meets primary endpoint
November 02, 2009 08:44 ET
|
ALK Abello
The investigational sublingual allergy immunotherapy tablet (GRAZAX®) meets
primary endpoint in a study of adult subjects with a history of grass pollen
allergies.
Schering-Plough Corporation, ALK's...